Cohance Lifesciences (COHANCE.NSE) Q1 2026 Earnings

12FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
0.98
1.82
2.66
3.5

Details

Expected EPS
2.7136019804914624
Actual EPS
0.9823374721875
Surprise EPS
-1.73
Surprise Percent
+63.8%

Description

Cohance Lifesciences (COHANCE.NSE) has reported earnings of 0.9823374721875 per share for Q1 2026.

0 Comments

Share your thoughts